BRCA1 and pancreatic neoplasm: However, recent data have sparked debate over just how predictive BRCA1/2-mutated cancers can be to PARPis, especially in non-BRCA-associated cancer types (cancers not including breast, ovary, prostate, or pancreatic cancer) [56].